Tue: Oil Refineries plunge fails to halt market rally

Oil Refineries has lost 27% in the past two sessions, while Bezeq was today's biggest gainer on the Tel Aviv 25 Index.

The Tel Aviv Stock Exchange (TASE) rose today. The Tel Aviv 25 Index rose 0.12% % to 1,282.07 points, the Tel Aviv 100 Index rose 0.22% to 1,159.52 points, and the BlueTech 50 Index rose 0.16% to 334.37 points. Turnover was NIS 1.14 billion.

The TASE rally continued today, albeit weaker than yesterday, despite losses on European markets and a mixed opening on Wall Street.

In the foreign currency market, the Bank of Israel set the shekel-dollar representative exchange rate at NIS 3.561/$, up 0.57% on yesterday's rate, and set the shekel-euro representative exchange rate at NIS 4.832/€, up 0.51%.

In the bond market, long-term Shahar unlinked shekel government bonds and long term Galil CPI-linked government bonds fell. The corporate bond benchmark Tel-Bond 20 Index 0.08%.

In the stock market, Oil Refineries Ltd. (TASE:ORL) fell another 18%, for the biggest loss among Tel Aviv 25 shares, and on the day's biggest turnover of NIS 116.4 million. The share has fallen 27% in two days, amid concerns about the debt settlement by one of its parent companies, Israel Petrochemical Enterprises Ltd. (TASE:PTCH). Petrochemical Enterprises fell another 14.4% today.

Oil Refineries' sister company Israel Chemicals Ltd. (TASE: ICL) fell 0.6%, and their parent company, Israel Corporation (TASE: ILCO), fell 2.1%. ,p>Bezeq Israeli Telecommunication Co. Ltd. (TASE: BEZQ) rose 2.4%, for the biggest gain among Tel Aviv 25 shares.

On the Tel Aviv 100 Index, Ceragon Networks Ltd. (Nasdaq: CRNT; TASE:CRNT) rose 1.4%, after announcing a Tanzanian contract, and Magic Software Enterprises Ltd. (Nasdaq: MGIC; TASE: MGIC) 1.2%, after announcing an acquisition in the US. Ormat Industries Ltd. (TASE: ORMT) rose 1.8%, after announcing an Indonesian deal.

RedHill Biopharma Ltd. (Nasdaq: RDHL); TASE: RDHL) fell 1.2%, despite reporting success in a clinical trial, ahead of an application to the US Food and Drug Administration (FDA), and Kitov Pharmaceutical Holdings Ltd. (TASE: KTOV) fell 5.1%, after announcing plans to list American Depository Receipts (ADRs) on Wall Street.

Published by Globes [online], Israel business news - www.globes-online.com - on October 8, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018